-
-
-
-
-
-
-
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Period Progress
-
-
-
-
-
-
-
Truist Securities: 'Is Biotech Back?!'
-
-
-
-
-
-
-
Alnylam to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Redburn-Atlantic Starts Alnylam Pharmaceuticals (ALNY) at Buy
-
-
-
-
-
-
-
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2024 Global Net Product Revenues and Provides 2025 Combined Net Product Revenue Guidance and Pipeline Goals
-
-
-
-
-
-
-
Alnylam Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Period Activity
-
-
-
-
-
-
-
Alnylam Pharma (ALNY) Tops Q4 EPS by 49c; offers guidance
-
1,198,886 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

